Pulmatrix, Inc. (PULM)
NASDAQ: PULM · Real-Time Price · USD
1.360
-0.150 (-9.93%)
At close: Mar 27, 2026, 4:00 PM EDT
1.400
+0.040 (2.94%)
After-hours: Mar 27, 2026, 5:28 PM EDT
Pulmatrix Market Cap
Pulmatrix has a market cap or net worth of $4.97 million as of March 27, 2026. Its market cap has decreased by -83.23% in one year.
Market Cap
4.97M
Enterprise Value
879.11K
1-Year Change
-83.23%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since June 16, 2015, Pulmatrix's market cap has decreased from $165.85M to $4.97M, a decrease of -97.01%. That is a compound annual growth rate of -27.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 5.51M | -32.29% |
| Dec 31, 2025 | 8.14M | -68.05% |
| Dec 31, 2024 | 25.49M | 275.27% |
| Dec 29, 2023 | 6.79M | -51.89% |
| Dec 30, 2022 | 14.12M | -42.64% |
| Dec 31, 2021 | 24.61M | -39.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bolt Biotherapeutics | 8.65M |
| Imunon | 8.54M |
| PharmaCyte Biotech | 8.17M |
| Kiora Pharmaceuticals | 8.06M |
| Addex Therapeutics | 7.94M |
| TransCode Therapeutics | 7.83M |
| BiomX | 7.79M |
| Aprea Therapeutics | 7.68M |